This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Paediatrics
Fumaric acid esters effective in children with moderate to severe psoriasis
Read more
Study examines UK death rate and hospital admissions for food allergies
Read more
Increased risk of asthma with PPI use in children
Read more
Topical steroids normalise inflammatory markers in infants with atopic eczema
Read more
Differences in immune and clotting functioning may explain less severe COVID-19 in children
Read more
Nebulised magnesium has no effect on hospitalisation in acute refractory asthma
Read more
Early introduction of gluten reduces incidence of coeliac disease
Read more
Study analyses immune response to COVID-19 in young people
Read more
Live-bacterial spray improves disease severity in children with atopic eczema
Read more
Vitamin D has little impact on asthma exacerbations in high risk children
Read more
School children could play a role in spreading COVID-19
Read more
Cosentyx® receives EU approval as first-line system for paediatric psoriasis
Read more
First oral therapy for peanut allergy approved by FDA
Read more
Addition of rituximab improves survival in children with B-cell lymphomas
Read more
Children show increase in mental health difficulties over COVID-19 lockdown
Read more
Parents of children with asthma value written information from their specialist
Read more
Children and COVID-19: is it safe to return to school?
Read more
Page 6 of 16
« First
«
...
4
5
6
7
8
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: